Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Brainlab

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Brainlab see related information
Date Initiated by Firm November 19, 2014
Date Posted January 15, 2015
Recall Status1 Terminated 3 on March 28, 2018
Recall Number Z-0957-2015
Recall Event ID 69960
510(K)Number K053584  K080888  K103246  
Product Classification System,planning,radiation therapy treatment - Product Code MUJ
Product iPlan RT is a radiation treatment planning system that is intended for use in stereotactic, conformal, computer planned, Linac based radiation treatment of cranial, head and neck, and extracranial lesions.
Code Information Software Versions:   1) 21213 IPLAN RT DOSE 3.0 PLATFORM;  2) 21213A IPLAN RT DOSE 3.0.1 PLATFORM;  3) 21213B IPLAN RT DOSE 3.0.2 PLATFORM;  4) 21213D IPLAN RT DOSE 4.1.0 PLATFORM;  5) 21213E IPLAN RT DOSE 4.1.1 PLATFORM;  6) 21213F IPLAN RT DOSE 4.1.2 PLATFORM;  7) 21213G IPLAN RT DOSE 4.1.3 PLATFORM;  8) 21213H IPLAN RT DOSE 4.1.4 PLATFORM;  9) 21381 IPLAN RT DOSE 4.5.0 PLATFORM;  10) 21381A IPLAN RT DOSE 4.5.1 PLATFORM;  11) 21381B IPLAN RT DOSE 4.5.2 PLATFORM;  12) 21381C IPLAN RT DOSE 4.5.3 PLATFORM;  13) 21385 UPGRADE IPLAN RT DOSE 4.X TO 4.5.0;  14) 21385A UPGRADE IPLAN RT DOSE 4.X TO 4.5.1;  15) 21385B UPGRADE IPLAN RT DOSE 4.X TO 4.5.2;  16) 21385C UPGRADE IPLAN RT DOSE 4.X TO 4.5.3;  17) 21387 iPLAN RT DOSE PLATFORM 4.1 (21213);  18) 21387A iPLAN RT DOSE PLATFORM 4.1.2 (21213);  19) 21387B iPLAN RT DOSE PLATFORM 4.5.1 (21381);  20) 21387C iPLAN RT DOSE PLATFORM 4.5.2 (21381);  21) 21387D IPLAN RT DOSE PLATFORM 4.5.3(21381) V;  22) 70213 UPGRADE BRAINSCAN 5.X TO iPLAN RT DOSE 3;  23) 70213A UPGRADE BRAINSCAN 5.X TO iPLAN RT DOSE 3;  24) 70213B UPG BRAINSCAN 5.X TO iPLAN RT DOSE 3.0;  25) 70213C UPG BRAINSCAN 5.X TO iPLAN RT DOSE4.1.0;  26) 70213D UPG BRAINSCAN 5.X TO iPLAN RT DOSE 4.1.1;  27) 70213E UPG BRAINSCAN 5.X TO iPLAN RT DOSE 4.1.2;  28) 70213F UPG BRAINSCAN 5.X TO iPLAN RT DOSE 4.5.1;  29) 70214 UPGRADE BRAINSCAN 3.X/ 4.X TO IPLAN RT D;  30) 70214A UPGRADE BRAINSCAN 3.X/ 4.X TO IPLAN RT D;  31) 70214B UPG BRAINSC 3.X/4.X TO IPLAN RT DOSE 3.0;  32) 70214C UPG BRAINSC. 3/4.X - iPLAN RT DOSE 4.1.0;  33) 70214D UPG BRAINSC. 3/4.X - iPLAN RT DOSE 4.1.1;  34) 70214E UPG BRAINSC. 3/4.X - iPLAN RT DOSE 4.1.2;  35) 70214F UPG BRAINSC. 3/4.X - iPLAN RT DOSE 4.5.1;  36) 70226 UPGRADE IPLAN RT DOSE 3.0 TO 3.0.1;  37) 70226A UPGRADE IPLAN RT DOSE TO 3.0.2;  38) 70228 UPGRADE IPLAN RT DOSE 3.X TO 4.0;  39) 70228A UPG IPLAN RT DOSE 3.X TO 4.1.0;  40) 70228B UPG IPLAN RT DOSE 3.X TO 4.1.1;  41) 70228C UPG IPLAN RT DOSE 3.X TO 4.1.2;  42) 70228D UPG IPLAN RT DOSE 3.X TO 4.5.1;  43) 70228E UPG IPLAN RT DOSE 3.X TO 4.5.2;  44) 70228F UPG IPLAN RT DOSE 3.X TO 4.5.3;  45) 70235 UPGRADE BRAINSCAN TO IPLAN RT DOSE 4.5;  46) 70235A UPGRADE BRAINSCAN TO IPLAN RT DOSE 4.5.2;  47) 70235B UPGRADE BRAINSCAN TO IPLAN RT DOSE 4.5.3;  48) 70237 UPD IPLAN RT DOSE 4.x TO 4.5 (0TRANSFER);  49) 70237A UPD IPLAN RT DOSE 4.x TO 4.5.2 (O TRANS);  50) 70237B UPD IPLAN RT DOSE 4.x TO 4.5.3(O TRANS);  51) 70263 UPD IPLAN RT DOSE 4.1.x to 4.1.3.(0TRA);  52) 70440 UPD iPLAN RT DOSE 4.1.0 TO 4.1.1;  53) 70440A UPD iPLAN RT DOSE 4.1 TO 4.1.2;  54) 20146 2ND LICENCE SW - FOR ONE ADDITIONAL WS;  55) 20147 RT SRS 2ND LICENCE SW FOR ONE ADD SITE;  56) 20148 NOVALIS TX 2ND LICENCE SW ONE ADD SITE
Recalling Firm/
Manufacturer		 Brainlab AG
Kapellenstrasse 12
Feldkirchen Germany
For Additional Information Contact
800-5975911
Manufacturer Reason
for Recall		 iPlan RT Radiation Treatment Planning Software: Potentially incorrect patient positioning when using multiple localized CT image data sets.
FDA Determined
Cause 2		 Software in the Use Environment
Action Brainlab sent a FIELD SAFETY NOTICE / PRODUCT NOTIFICATION letter dated November 19, 2014, to all affected customers. The letter included instructions to: 1) If clinically not required, do not use multiple localized CT scans within one treatment plan (to avoid potentially incorrect Reference and Alignment Set assignments in the first place). 2) If you must use multiple localized CT scans, e.g. for recurrent treatment planning of the same patient, always guarantee that the latest (see note *) CT scan is defined as both Alignment Set and Reference Set during treatment planning. Brainlab will provide a software solution to prevent the described scenario from occurring. Brainlab will actively contact affected customers tentatively starting January 2016 to schedule the update. Brainlab will additionally refine the instructions for use of the iPlan RT treatment planning software in regard to implications of Alignment Set and Reference Set selections and will provide this user guide update to existing affected customers together with the software update. Customers with questions can contact Brainlab at 800-597-5911 or via e-mail at us.support@brainlab.com.
Quantity in Commerce 1412 systems total
Distribution Worldwide Distribution - USA including Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, Wyoming and Internationally to Algeria, Angola, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Dominican Republic, Ecuador, Finland, France, Germany, Greece, Honduras, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Kazakhstan, Latvia, Lebanon, Lithuania, Malaysia, Mexico, Netherlands, Norway, Oman, Panama, Poland, Portugal, Qatar, Romania, Russian Federation, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Thailand, Tunisia, Turkey, Ukraine, United Kingdom, Uruguay, and Venezuela.
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database 510(K)s with Product Code = MUJ and Original Applicant = BRAINLAB AG
510(K)s with Product Code = MUJ and Original Applicant = BRAINLAB, AG
-
-